As we move through 2026, the biopharma industry is hitting a major sustainability milestone. For years, the move to Single-Use Technology (SUT) was criticized for its plastic waste. Today, one step towards solving that paradox that has been presented is Bio-based Polymers.
Today, we’re proud to introduce Owen McMaster, our motivated and resourceful Project Manager / Engineer-in-Training (EIT).
Today, we’re proud to introduce the professional who bridges complex engineering with validated execution: Colin Young, our Project Manager and Validation Scientist.
I love the smell of a fresh Gantt chart in the morning. It’s the only time the project is actually on schedule.
Meet Petroslava “Petia” Ivanova, our Aseptic Filling & Sterile Manufacturing SME:
It is once again time for another instalment of our weekly feature: Meet-the-Team-Thursdays!
Today, we would like to introduce to you our esteemed colleague, John Teixeira:
We would like to introduce you to John Storrie, our Environmental Monitoring and GMP Training expert:
Let’s be honest, managing projects for bioprocessing facilities can feel like herding cats made of critical deadlines, regulatory demands, and a budget that’s always trying to escape.
But fear not, fellow project managers! We’ve got a secret weapon that turns chaos into controlled brilliance (most of the time): Risk-Based Project Management.
New year, same mission — just a little less stress? 🥂
You know that feeling when you’ve just completed a massive project, validation is complete, and you’re ready to ship product? That sweet relief is immediately followed by the cold dread of realizing the FDA Pre-Approval Inspection (PAI) is looming…
In aseptic manufacturing, the PAI isn’t just an inspection -it’s the regulatory World Series, the Aseptic Olympics- success demands a flawless routine without dropping any SOPs. The medal is market access; the judge is the FDA.
Copyright (c) 2025, GPharma Solutions Ltd; all rights reserved.
Template by Bootstrapious. Ported to Hugo by DevCows.
